Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GP681 pediatric influenza phase 2 trial
CTR20242480Phase 2Completed
- Sponsor
- Jiangxi Qingfeng Pharmaceutical Co. Ltd.
- Start
- Sep 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of suraxavir marboxil in Influenza A infection, influenza B, sponsored by Jiangxi Qingfeng Pharmaceutical Co. Ltd.. Started Sep 2024; status: completed.
02
Drugs
suraxavir marboxil
03
Conditions
Influenza A infectioninfluenza B
Beyond the preview
Go deeper on CTR20242480.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20242480.